Skip to main content

Month: May 2021

Wilmington Announces 2021 First Quarter Results

CALGARY, Alberta, May 05, 2021 (GLOBE NEWSWIRE) — Wilmington Capital Management Inc. (“Wilmington” or the “Corporation”) reported net loss attributable to shareholders for the three months ended March 31, 2021 of $0.03 million or $0.00 per share compared to a net loss of $0.3 million or ($0.03) per share for the same period in 2020. OPERATIONS REVIEW – For the Period Ended March 31, 2021As at March 31, 2021, Wilmington had assets under management in its operating platforms of approximately $245 million ($75 million representing Wilmington’s share). A summary of the Corporation and the operation of its investments is set out below. MarinasMaple Leaf PartnershipsIn March 2021, the Corporation invested an additional $1.1 million in the Maple Leaf Partnerships, being its proportionate share, of capital, to acquire...

Continue reading

Root, Inc. Announces 2021 First Quarter Results

COLUMBUS, Ohio, May 05, 2021 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), the parent company of Root Insurance Company, today announced financial results for the quarter ended March 31, 2021. Root’s first quarter financial results and management commentary can be found by accessing the shareholder letter posted to the company’s investor relations website at ir.joinroot.com. Root will host a conference call and earnings webcast to discuss the results tomorrow, Thursday, May 6, at 8:00 a.m. Eastern Time, and to provide an update on company operations. To listen to the live audio webcast, please visit the News & Events section of Root’s Investor Relations website at ir.joinroot.com. A replay will be available on the same website following the call. Webcast and Conference Call DetailsDate: May 6, 2021  Time: 8:00 a.m. ET  Dial-in: (833)...

Continue reading

Allarity Therapeutics Updates Preliminary Timetable for Planned Rights Issue

Press release Hørsholm, Denmark (5 May 2021) Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced an update of the preliminary timetable for the planned Rights Issue announced on 23 March 2021. Updated preliminary timetable for the Rights Issue17 May 2021: Publication of the EU growth prospectus. 18 May 2021: Last day of trading in the share, including the right to receive subscription rights. 19 May 2021: First day of trading in the share, excluding the right to receive subscription rights. 20 May 2021: Record date for participation in the Rights Issue, i.e. holders of shares who are registered in the share register maintained by Euroclear Sweden AB on this date will receive subscription rights for participation in the Rights Issue with preferential right. 25 May – 3 June 2021: Trading in subscription rights. 25 May...

Continue reading

Mid Penn Bank Originates Over $1 Billion in PPP Loans Helping to Save Over 89,000 Jobs

MILLERSBURG, Pa., May 05, 2021 (GLOBE NEWSWIRE) — Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MPB), parent company of the wholly-owned subsidiaries Mid Penn Bank (“Bank”) and MPB Financial Services, Inc., announced today that the Bank has approved and disbursed more than $370 million in loans for small businesses since the 2021 Paycheck Protection Program (PPP) portal was opened for community banks in January. Mid Penn Bank has provided loans for more than 3,300 businesses in the 2021 Program. The Small Business Administration backed loans received by these employers has allowed them to retain more than 34,000 workers on their payrolls. The Bank’s SBA team relied on the experience gained in the first round of PPP in 2020 to help business owners and managers efficiently and successfully apply for and receive this critical funding....

Continue reading

Minerva Neurosciences to Report First Quarter 2021 Financial Results and Business Updates on May 12, 2021

Management to host conference call WALTHAM, Mass., May 05, 2021 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that it will release financial results and business updates for the first quarter of 2021 on Wednesday, May 12, 2021. The Company will host a webcast and conference call that day at 8:30 a.m. Eastern Time to discuss these results and updates. The live call may be accessed by dialing (877) 312-5845 (domestic) or (765) 507-2618 (international) and referring to conference ID number 8981662. A live webcast of the conference call will be available online in the Investors and Media section of the Company’s website at ir.minervaneurosciences.com. The archived webcast...

Continue reading

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2021 and Declares Quarterly Dividend

TORONTO, May 05, 2021 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2021 and declared a $1.00 per share dividend payable on July 10, 2021 to all common shareholders of record at close of business on June 19, 2021. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated. The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three months ended March 31, 2021 and the accompanying notes, our Management Discussion and Analysis for the three months ended March...

Continue reading

Firm Capital Property Trust Announces Closing of Lower Sackville Property Acquisition Comprised of 132 Units for $18.0 Million

TORONTO, May 05, 2021 (GLOBE NEWSWIRE) — Firm Capital Property Trust (“FCPT” or the “Trust“) (TSXV: FCD.UN) is pleased to announce the closing of the previously announced acquisition of 132 units in three multi-residential buildings located in Lower Sackville, Nova Scotia (the “Lower Sackville Property”) for approximately $18.0 million (excluding transaction costs). The Lower Sackville Property is located in proximity to downtown Halifax and is conveniently located to schools, public transportation, shopping, restaurants, and entertainment. The Lower Sackville Property has enjoyed strong 98% occupancy rates or higher since 2018. The Lower Sackville Property was purchased for approximately $136,300 per unit or $113 per square foot. The Lower Sackville Property was financed with a new $13.7 million mortgage...

Continue reading

Disclosure of Voting Rights in IDEX Biometrics – Chair Morten Opstad – 5 May 2021

At the close of business on 5 May 2021, Morten Opstad, Chair of the Board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the Extraordinary General Meeting on 12 May 2021: Total 172,557,729 shares or 18,82% of the share capital and votes, consisting of the following:Proxy to present and vote for 73,181,240 shares or 7,98% of the share capital, including shares held by Mr Opstad and close relations Proxy with voting instructions for 99,376,489 shares or 10,84% of the share capital.For further information contact: Marianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.com Tel: + 47 918 00186 Brett L Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: + 1 214 272 0070 About IDEX Biometrics IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDXBA) is a leading provider of fingerprint...

Continue reading

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

Montrouge, France, May 5, 2021 DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced the filing of its first Form 10-Q for the quarter ended March 31, 2021 with the U.S. Securities and Exchange Commission (SEC). This document can be accessed on the Investors & Media section of the Company’s website at www.dbv-technologies.com. In addition, this Form 10-Q is available on the SEC’s website at www.sec.gov. About DBV Technologies DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, DBV’s method of delivering...

Continue reading

SJI Reports First Quarter 2021 Results

Investor Day To Provide Long-Term Growth Outlook FOLSOM, NJ , May 05, 2021 (GLOBE NEWSWIRE) —Investor Contact:Daniel Fidell609-561-9000 x7027dfidell@sjindustries.com Media Contact:Dominick DiRocco609-561-9000 x4262ddirocco@sjindustries.comSJI Reports First Quarter 2021 ResultsInvestor Day To Provide Long-Term Growth Outlook FOLSOM, NJ (May 5, 2021) – SJI (NYSE: SJI) today reported operating results for the first quarter ended March 31, 2021. Highlights include:Q1 2021 GAAP earnings of $1.26 per diluted share compared to $1.09 per diluted share in 2020 Q1 2021 Economic Earnings* of $1.26 per diluted share compared to $1.15 per diluted share in 2020 First quarter results reflect increased profitability from Utility and Non-Utility operations partially offset by impact of financing activities Successful...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.